Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01761604 · ClinicalTrials.gov registry record · NA
A Nasal Applicator for the Treatment of Trigeminal Neuralgia
A NA study, sponsored by Chicago Anesthesia Pain Specialists.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01761604: Completed NA study, sponsored by Chicago Anesthesia Pain Specialists.
NCT01761604 is a NA study that has completed, run by Chicago Anesthesia Pain Specialists. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01761604, a NA study, has completed, sponsored by Chicago Anesthesia Pain Specialists.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The pain from Trigeminal Neuralgia (TN) imposes a substantial burden on patients in daily function and reduces quality of life. The sphenopalatine ganglion, located in the posterior part of the middle nasal turbinate, is involved in the pain associated to TN, by blocking the sphenopalatine ganglion relieves patients from the symptoms. However, methods currently in use to accomplish this are either cumbersome for the patient or invasive regarding the puncture of structures. The purpose of this study is to evaluate the efficacy of Tx360™, a new nasal applicator device, in the treatment of TN. A local anesthetic will be delivered on the ganglion area. We are expecting that this new device will provide at least the same pain relief as the previously described approaches. However, this nasal applicator is intended to be an easy and non invasive method for office use.
Primary Outcome
Change in pain intensity before procedure, baseline. And after procedure 15 minutes, 30 minutes, day 1, 7, 14, 21, and 28.
Interventions
- DEVICE Nasal ganglion block for TN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2011-12 |
| Est. Completion | 2017-09 |
| Phase | NA |
What the finished NCT01761604 record still lists
NCT01761604 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Nasal ganglion block for TN is the first listed.
NCT01761604 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01761604 about?
NCT01761604 is a clinical study titled "A Nasal Applicator for the Treatment of Trigeminal Neuralgia". The pain from Trigeminal Neuralgia (TN) imposes a substantial burden on patients in daily function and reduces quality of life. The sphenopalatine ganglion, located in the posterior part of the middle nasal turbinate, is involved in the pain associated to TN, by blocking the sphenopalatine ganglion ...
What is the current status of trial NCT01761604?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2011-12. Estimated completion is 2017-09.
What interventions are being tested in trial NCT01761604?
The interventions under investigation include: Nasal ganglion block for TN (DEVICE).
Who is sponsoring clinical trial NCT01761604?
This trial is sponsored by Chicago Anesthesia Pain Specialists, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01761604's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia